RCMF

RCMF predicts microRNA-disease associations (MDAs) using robust collaborative matrix factorization with L2,1-norm regularization to handle sparse disease matrices and improve prediction accuracy.

Key Features:

• Robust Collaborative Matrix Factorization: Employs collaborative matrix factorization tailored to handle sparsity in disease matrices.
• L2,1-norm Regularization: Incorporates L2,1-norm regularization to mitigate effects of sparse data and reportedly achieves higher Area Under the Curve (AUC) values versus comparative methods.
• 5-Fold Cross-Validation: Uses 5-fold cross-validation to evaluate model reliability and predictive performance.
• Simulation Experiments on Gold Standard Dataset: Validates predictive effectiveness through simulation experiments conducted on a Gold Standard Dataset.

Scientific Applications:

• Identification of Novel MDAs: Supports discovery of previously unknown associations between microRNAs and diseases.
• Enhanced Research Efficiency: Provides an approach aimed at reducing computational challenges associated with sparse MDA matrices, facilitating more efficient prediction workflows.

Methodology:

Applies robust collaborative matrix factorization with L2,1-norm regularization, evaluated using 5-fold cross-validation and simulation experiments on a Gold Standard Dataset.